D64.81 – Anemia due to antineoplastic chemotherapy

ICD-10-CM 2027 diagnosis code · Aplastic and other anemias and other bone marrow failure syndromes

Billable code

ICD-10-CM code D64.81

Code: D64.81 (claims format: D6481)
Description: Anemia due to antineoplastic chemotherapy
Billable: Yes – valid for HIPAA-covered transactions
Valid for: Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter: 3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Block: D60-D64 Aplastic and other anemias and other bone marrow failure syndromes
Parent codes: D64 › D64.8

Notes for D64.81

Applicable to:

Antineoplastic chemotherapy induced anemia

Excludes2 (not included here):

anemia in neoplastic disease (D63.0)
aplastic anemia due to antineoplastic chemotherapy (D61.1)

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

D64 – Other anemias

Excludes1 (not coded here):

refractory anemia (D46.-)
refractory anemia with excess blasts in transformation [RAEB T] (C92.0-)

Index terms for D64.81

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in D64.8

D64.89 – Other specified anemiasBillable

Frequently asked questions

What is ICD-10 code D64.81?

D64.81 is the ICD-10-CM code for anemia due to antineoplastic chemotherapy, in the block D60-D64 (Aplastic and other anemias and other bone marrow failure syndromes).

Is D64.81 a billable code?

Yes. D64.81 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does D64.81 belong to?

It belongs to category D64 – Other anemias.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.